{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:18:57Z","timestamp":1793423937910,"version":"4.5.0"},"reference-count":246,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Anti-M\u00fcllerian hormone (AMH) is a peptide belonging to the transforming growth factor beta superfamily and acts exclusively through its receptor type 2 (AMHR2). From the 8\n                    <jats:sup>th<\/jats:sup>\n                    week of pregnancy, AMH is produced by Sertoli cells, and from the 23\n                    <jats:sup>rd<\/jats:sup>\n                    week of gestation, it is produced by granulosa cells of the ovary. AMH plays a critical role in regulating gonadotropin secretion, ovarian tissue responsiveness to pituitary hormones, and the pathogenesis of polycystic ovarian syndrome. It inhibits the transition from primordial to primary follicles and is considered the best marker of ovarian reserve. Therefore, measuring AMH concentration of the hormone is valuable in managing assisted reproductive technologies. AMH was initially discovered through its role in the degeneration of M\u00fcllerian ducts in male fetuses. However, due to its ability to inhibit the cell cycle and induce apoptosis, it has also garnered interest in oncology. For example, antibodies targeting AMHR2 are being investigated for their potential in diagnosing and treating various cancers. Additionally, AMH is present in motor neurons and functions as a protective and growth factor. Consequently, it is involved in learning and memory processes and may support the treatment of Alzheimer\u2019s disease. This review aims to provide a comprehensive overview of the biology of AMH and its role in both endocrinology and oncology.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2024.1468364","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:42:39Z","timestamp":1726447359000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Anti-M\u00fcllerian hormone: biology and role in endocrinology and cancers"],"prefix":"10.3389","volume":"15","author":[{"given":"Marek","family":"Gowkielewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Lipka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zdanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Wa\u015bniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Majewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Carlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.15.5464","article-title":"Cloning and expression","volume":"83","author":"Picard","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2003.10.004","article-title":"The transforming growth factor-\u03b2 superfamily of receptors","volume":"15","author":"De Caestecker","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"B3","article-title":"Zaburzenia kaskady transformuj\u0105cych czynnik\u00f3w wzrostu typu \u03b2 w wybranych patologiach cz\u0142owieka Aberrations in the signalling cascade of transforming growth factor \u03b2 type in selected human pathologies Wst\u0119p","volume":"39","author":"Zakrzewski","year":"2012","journal-title":"Folia Med Lodziensia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000132332","article-title":"Mapping of the gene for anti-m\u00fcllerian hormone to the short arm of human chromosome 19","volume":"44","author":"Cohen-Haguenauer","year":"1987","journal-title":"Cytogenet Cell Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101634","article-title":"Genetics of anti-M\u00fcllerian hormone and its signaling pathway","volume":"36","author":"Josso","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00187.2011","article-title":"SOX9 and SF1 are involved in cyclic AMP-mediated upregulationof anti-M\u00fcllerian gene expression in the testicular prepubertal Sertoli cell line SMAT1","volume":"301","author":"Lasala","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"bqaa066","DOI":"10.1210\/ENDOCR\/BQAA066","article-title":"Mutational analysis of the putative Anti-M\u00fcllerian Hormone (AMH) binding interface on its type II receptor, AMHR2","volume":"161","author":"Hart","year":"2020","journal-title":"Endocrinology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/ENDO.140.5.6705","article-title":"High specificity of M\u00fcllerian-inhibiting substance signaling in vivo","volume":"140","author":"Mishina","year":"1999","journal-title":"Endocrinology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","article-title":"Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells","volume":"96","author":"Pellatt","year":"2011","journal-title":"Fertil Steril"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208686","article-title":"Role of type I receptors for anti-M\u00fcllerian hormone in the SMAT-1 Sertoli cell line","volume":"24","author":"Belville","year":"2005","journal-title":"Oncogene"},{"key":"B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0014-5793(01)02712-0","article-title":"Topogenesis of membrane proteins: Determinants and dynamics","volume":"504","author":"Goder","year":"2001","journal-title":"FEBS Lett"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.905324","article-title":"Anti-M\u00fcllerian Hormone signal transduction involved in M\u00fcllerian duct regression","volume":"13","author":"Cate","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/me.15.6.936","article-title":"The serine\/threonine transmembrane receptor ALK2 mediates M\u00fcllerian inhibiting substance signaling","volume":"15","author":"Visser","year":"2001","journal-title":"Mol Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1074\/JBC.M002704200","article-title":"Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-M\u00fcllerian hormone and its type II receptor","volume":"275","author":"Gou\u00e9dard","year":"2000","journal-title":"J Biol Chem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1677\/ERC-07-0168","article-title":"Transforming growth factor-\u03b2 signaling and ubiquitinators in cancer","volume":"15","author":"Glasgow","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2443.2002.00599.x","article-title":"Two major Smad pathways in TGF-\u03b2 superfamily signalling","volume":"7","author":"Miyazawa","year":"2002","journal-title":"Genes to Cells"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202133260707","article-title":"M\u00fcllerian inhibiting substance as a marker for ovarian sex-cord tumor","volume":"326","author":"Gustafson","year":"1992","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.01.028","article-title":"Evidence for a M\u00fcllerian-inhibiting substance autocrine\/paracrine system in adult human endometrium","volume":"91","author":"Wang","year":"2009","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(98)90454-3","article-title":"Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors","volume":"29","author":"Matias-Guiu","year":"1998","journal-title":"Hum Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181a702d1","article-title":"The role of inhibins B and antim\u00fcllerian hormone for diagnosis and follow-up of granulosa cell tumors","volume":"19","author":"Geerts","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201902217R","article-title":"Rapid actions of anti-M\u00fcllerian hormone in regulating synaptic transmission and long-term synaptic plasticity in the hippocampus","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20061325","article-title":"Anti-m\u00fcllerian hormone expression in endometrial cancer tissue","volume":"20","author":"Gowkielewicz","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508304102","article-title":"Mullerian Inhibiting Substance acts as a motor neuron survival factor in vitro","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.47198","article-title":"Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism","volume":"8","author":"Malone","year":"2019","journal-title":"Elife"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0407772101","article-title":"Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance","volume":"102","author":"Renaud","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004554200","article-title":"Mullerian inhibiting substance inhibits breast cancer cell growth through an NF\u03baB-mediated pathway","volume":"275","author":"Segev","year":"2000","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.221599298","article-title":"Mullerian-inhibiting substance regulates NF-\u03baB signaling in the prostate in vitro and in vivo","volume":"99","author":"Segev","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607959103","article-title":"Mullerian inhibiting substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer","volume":"103","author":"Pieretti-Vanmarcke","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/biology10040305","article-title":"The expression of anti-m\u00fcllerian hormone type II receptor (AMHRII) in non-gynecological solid tumors offers potential for broad therapeutic intervention in cancer","volume":"10","author":"Barret","year":"2021","journal-title":"Biol (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1538","article-title":"M\u00fcllerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis","volume":"97","author":"Namkung","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M005701200","article-title":"Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism","volume":"275","author":"Ha","year":"2000","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2636900100","article-title":"Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107","volume":"100","author":"Barbie","year":"2003","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.3390\/cells9102312","article-title":"Anti-M\u00fcllerian Hormone type II receptor expression in endometrial cancer tissue","volume":"9","author":"Gowkielewicz","year":"2020","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.2.594","article-title":"Receptors for anti-M\u00fcllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation","volume":"95","author":"Racine","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/endo.136.11.7588229","article-title":"Anti-m\u00fcllerian hormone and anti-m\u00fcllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth","volume":"136","author":"Baarends","year":"1995","journal-title":"Endocrinology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.1.8536608","article-title":"Developmental expression of a candidate m\u00fcllerian inhibiting substance type II receptor","volume":"137","author":"Teixeira","year":"1996","journal-title":"Endocrinology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.06.043","article-title":"Anti-M\u00fcllerian Hormone signaling regulates epithelial plasticity and chemoresistance in lung cancer","volume":"16","author":"Beck","year":"2016","journal-title":"Cell Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu Rev Pathol: Mech Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14090","article-title":"Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer","volume":"284","author":"Sciacovelli","year":"2017","journal-title":"FEBS J"},{"key":"B40","article-title":"Cleavage of M\u00fcllerian inhibiting substance activates antiproliferative effects in vivo","volume":"1","author":"Kurian","year":"1995","journal-title":"Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.AAZ8528","article-title":"Cell type-specific genetic regulation of gene expression across human tissues","volume":"369","author":"Kim-Hellmuth","year":"2020","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2017.237","article-title":"Antimullerian hormone as indicator of ovarian dysfunction","volume":"13","author":"Bothou","year":"2017","journal-title":"Acta Endocrinol (Bucharest)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ygyno.2009.02.023","article-title":"Serum M\u00fcllerian Inhibiting Substance\/Anti-M\u00fcllerian Hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology","volume":"114","author":"Chang","year":"2009","journal-title":"Gynecol Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13048-022-01006-z","article-title":"Does Anti-M\u00fcllerian hormone vary during a menstrual cycle? A systematic review and meta-analysis","volume":"15","author":"Khodavirdilou","year":"2022","journal-title":"J Ovarian Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2014.57.5.343","article-title":"M\u00fcllerian inhibiting substance\/anti-M\u00fcllerian hormone: A novel treatment for gynecologic tumors","volume":"57","author":"Kim","year":"2014","journal-title":"Obstet Gynecol Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev.ge.27.120193.000443","article-title":"SRY AND SEX DETERMINATION IN MAMMALS","volume":"27","author":"Goodfellow","year":"1993","journal-title":"Annu Rev Genet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2003.09.022","article-title":"Anti-M\u00fcllerian hormone, \u03b2-catenin and M\u00fcllerian duct regression","volume":"211","author":"Xavier","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1242\/dev.127.15.3349","article-title":"Molecular mechanisms of hormone-mediated Mullerian duct regression: Involvement of \u03b2-catenin","volume":"127","author":"Allard","year":"2000","journal-title":"Development"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-1281(11)80202-3","article-title":"Expression of cytokeratins, vimentin and basement membrane components in human fetal male Mullerian duct and perimullerian mesenchyme","volume":"97","author":"Magro","year":"1995","journal-title":"Acta Histochem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/0012-1606(84)90238-0","article-title":"Timing and irreversibility of M\u00fcllerian duct inhibition in the embryonic reproductive tract of the human male","volume":"106","author":"Taguchi","year":"1984","journal-title":"Dev Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1159\/000518273","article-title":"AMH and AMHR2 involvement in congenital disorders of sex development","volume":"16","author":"Brunello","year":"2022","journal-title":"Sexual Dev"},{"key":"B52","first-page":"59","article-title":"The anti-M\u00fcllerian hormone","volume":"13","author":"Josso","year":"1977","journal-title":"Birth Defects Orig Artic Ser"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/141.2.466","article-title":"Sex-specific fetal lung development and Mullerian inhibiting substance","volume":"141","author":"Catlin","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-15931-3","article-title":"Temporal expression pattern of genes during the period of sex differentiation in human embryonic gonads","volume":"7","author":"Mamsen","year":"2017","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.919670","article-title":"Testicular sertoli cell hormones in differences in sex development","volume":"13","author":"Lucas-Herald","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.10.3836","article-title":"Expression of anti-Mullerian hormone during normal and pathological gonadal development: Association with differentiation of Sertoli and granulosa cells","volume":"84","author":"Rajpert-De Meyts","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2217\/fon.09.172","article-title":"M\u00fcllerian inhibiting substance\/anti-M\u00fcllerian hormone: A potential therapeutic agent for human ovarian and other cancers","volume":"6","author":"MacLaughlin","year":"2010","journal-title":"Future Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.10.7075","article-title":"Mullerian-inhibiting substance regulates androgen synthesis at the transcriptional level","volume":"140","author":"Teixeira","year":"1999","journal-title":"Endocrinology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0915","article-title":"Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in sertoli cells","volume":"93","author":"Chemes","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mce.2003.09.011","article-title":"Anti-M\u00fcllerian hormone levels in serum from human foetuses and children: Pattern and clinical interest","volume":"211","author":"Guibourdenche","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/345167a0","article-title":"Abnormal sexual development in transgenic mice chronically expressing M\u00fcllerian inhibiting substance","volume":"345","author":"Behringer","year":"1990","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90251-8","article-title":"M\u00fcllerian-inhibiting substance function during mammalian sexual development","volume":"79","author":"Behringer","year":"1994","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/en.2001-211352","article-title":"M\u00fcllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome P450 17\u03b1-hydroxylase\/C17-20 lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation","volume":"143","author":"Matt Laurich","year":"2002","journal-title":"Endocrinology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00619","article-title":"What does AMH tell us in pediatric disorders of sex development","volume":"11","author":"Josso","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.gmit.2016.11.001","article-title":"Complete androgen insensitivity syndrome and anti-M\u00fcllerian hormone levels before and after laparoscopic gonadectomy","volume":"6","author":"Kusumi","year":"2017","journal-title":"Gynecol Minim Invasive Ther"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13633-016-0038-2","article-title":"Anti-M\u00fcllerian hormone as a marker of steroid and gonadotropin action in the testis of children and adolescents with disorders of the gonadal axis","volume":"2016","author":"Edelsztein","year":"2016","journal-title":"Int J Pediatr Endocrinol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi014","article-title":"AMH and AMH receptor defects in persistent M\u00fcllerian duct syndrome","volume":"11","author":"Josso","year":"2005","journal-title":"Hum Reprod Update"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1159\/000475516","article-title":"The persistent M\u00fcllerian duct syndrome: an update based upon a personal experience of 157 cases","volume":"11","author":"Picard","year":"2017","journal-title":"Sexual Dev"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.10.003","article-title":"The long-term followup of 33 cases of true hermaphroditism: A 40-year experience with conservative gonadal surgery","volume":"177","author":"Verkauskas","year":"2007","journal-title":"J Urol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1502","article-title":"Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls","volume":"96","author":"Kuiri-H\u00e4nninen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by Anti-M\u00fcllerian Hormone in the mouse ovary1","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0022024","article-title":"A validated model of serum Anti-M\u00fcllerian hormone from conception to menopause","volume":"6","author":"Kelsey","year":"2011","journal-title":"PloS One"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(99)00639-1","article-title":"Serum mullerian-inhibiting substance levels during normal menstrual cycles","volume":"73","author":"Cook","year":"2000","journal-title":"Fertil Steril"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh508","article-title":"Anti-M\u00fcllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation","volume":"19","author":"La Marca","year":"2004","journal-title":"Hum Reprod"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00686","article-title":"Anti-M\u00fcllerian hormone during natural cycle presents significant intra and intercycle variations when measured with fully automated assay","volume":"9","author":"Melado","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2021.1938914","article-title":"Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective","volume":"17","author":"Kumariya","year":"2021","journal-title":"Autophagy"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1242\/dev.125211","article-title":"The developmental origins of the mammalian ovarian reserve","volume":"142","author":"Grive","year":"2015","journal-title":"Dev (Cambridge)"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0008772","article-title":"Human ovarian reserve from conception to the menopause","volume":"5","author":"Wallace","year":"2010","journal-title":"PloS One"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1051\/rnd:19790901","article-title":"The initiation of oocyte growth in the mouse ovary","volume":"19","author":"Lintern-Moore","year":"1979","journal-title":"Ann Biol Anim Biochim Biophys"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-M\u00fcllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: Renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0201-5","article-title":"Life, death and autophagy","volume":"20","author":"Doherty","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-018-0252-y","article-title":"Autophagy-dependent cell death","volume":"26","author":"Denton","year":"2019","journal-title":"Cell Death Differ"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000605RR","article-title":"HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS","volume":"34","author":"Zhang","year":"2020","journal-title":"FASEB J"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2019.7986","article-title":"Autophagy in female fertility: A role in oxidative stress and aging","volume":"32","author":"Peters","year":"2020","journal-title":"Antioxid Redox Signal"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1530\/REP-10-0265","article-title":"A differential autophagic response to hyperglycemia in the developing murine embryo","volume":"141","author":"Adastra","year":"2011","journal-title":"Reproduction"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1540567","article-title":"The role of androgen in autophagy of granulosa cells from PCOS","volume":"35","author":"Li","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-M\u00fcllerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.5713\/ajas.15.0797","article-title":"Role of Growth differentiation factor 9 and bone morphogenetic protein 15 in ovarian function and their importance in mammalian female fertility - A review","volume":"29","author":"De Castro","year":"2016","journal-title":"Asian-Australas J Anim Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201801089R","article-title":"AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice","volume":"33","author":"Sonigo","year":"2019","journal-title":"FASEB J"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2018.2228","article-title":"The role of autophagy in systemic metabolism and human-type diabetes","volume":"41","author":"Kim","year":"2018","journal-title":"Mol Cells"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-009-0448-1","article-title":"Analysis of different cell death processes of prepubertal rat oocytes in vitro","volume":"15","author":"Escobar","year":"2010","journal-title":"Apoptosis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1633592100","article-title":"Regulation of gonadotropin gene expression by M\u00fcllerian inhibiting substance","volume":"100","author":"B\u00e9d\u00e9carrats","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3133","article-title":"Differential regulation of ovarian anti-m\u00fcllerian hormone (AMH) by estradiol through \u03b1- and \u03b2-estrogen receptors","volume":"97","author":"Grynberg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-18-0313","article-title":"FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice","volume":"240","author":"Devillers","year":"2019","journal-title":"J Endocrinol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.1.8603","article-title":"Increased expression of M\u00fcllerian-inhibiting substance correlates with inhibition of follicular growth in the developing ovary of rats treated with E2 benzoate","volume":"143","author":"Ikeda","year":"2002","journal-title":"Endocrinology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1210\/me.2010-0297","article-title":"FSH and its second messenger cAMP stimulate the transcription of human anti-m\u00fcllerian hormone in cultured granulosa cells","volume":"25","author":"Taieb","year":"2011","journal-title":"Mol Endocrinol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-020-03576-x","article-title":"New insights into anti-M\u00fcllerian hormone role in the hypothalamic\u2013pituitary\u2013gonadal axis and neuroendocrine development","volume":"78","author":"Silva","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B100","doi-asserted-by":"publisher","first-page":"10055","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat Commun"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep23790","article-title":"Anti-Mullerian hormone: A new actor of sexual dimorphism in pituitary gonadotrope activity before puberty","volume":"6","author":"Garrel","year":"2016","journal-title":"Sci Rep"},{"key":"B102","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000494890","article-title":"GnRH transactivates human AMH Receptor Gene via Egr1 and FOXO1 in Gonadotrope Cells","volume":"108","author":"Garrel","year":"2019","journal-title":"Neuroendocrinology"},{"key":"B103","unstructured":"Antim\u00fc llerian Hormone in Patients with Hypogonadotropic Hypogonadism\n            YoungJ\n            ReyR\n            CouzinetB\n            ChansonP\n            JossoN\n            SchaisonG\n          10.1210\/jcem.84.8.5972J Clin Endocrinol Metab841999"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-019-01587-7","article-title":"Impact of hypogonadotropic hypogonadism on ovarian reserve and response","volume":"36","author":"Cecchino","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-014-0312-2","article-title":"Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH","volume":"31","author":"Chan","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1569-09.2009","article-title":"Regulation of gonadotropin-releasing hormone secretion by kisspeptin\/dynorphin\/neurokinin B neurons in the arcuate nucleus of the mouse","volume":"29","author":"Navarro","year":"2009","journal-title":"J Neurosci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"ENEURO.0362-22.2022","DOI":"10.1523\/ENEURO.0362-22.2022","article-title":"GnRH neuron excitability and action potential properties change with development but are not affected by prenatal androgen exposure","volume":"9","author":"Jaime","year":"2022","journal-title":"eNeuro"},{"key":"B108","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2042-6410-4-18","article-title":"Anti-M\u00fcllerian hormone may regulate the number of calbindin-positive neurons in the sexually dimorphic nucleus of the preoptic area of male mice","volume":"4","author":"Wittmann","year":"2013","journal-title":"Biol Sex Differ"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2011.09.054","article-title":"Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway","volume":"199","author":"Sun","year":"2011","journal-title":"Neuroscience"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101906","article-title":"Densities and numbers of calbindin and parvalbumin positive neurons across the rat and mouse brain","volume":"24","author":"Bjerke","year":"2021","journal-title":"iScience"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1055","article-title":"Calbindin knockout alters sex-specific regulation of behavior and gene expression in amygdala and prefrontal cortex","volume":"157","author":"Harris","year":"2016","journal-title":"Endocrinology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.celrep.2017.10.006","article-title":"Suppressed calbindin levels in hippocampal excitatory neurons mediate stress-induced memory loss","volume":"21","author":"Li","year":"2017","journal-title":"Cell Rep"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.21-04-01283.2001","article-title":"Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons","volume":"21","author":"Oppenheim","year":"2001","journal-title":"J Neurosci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1097-4547","article-title":"TGF-\u03b22 attenuates the injury-induced death of mature motoneurons","volume":"62","author":"Jiang","year":"2000","journal-title":"J Neurosci Res"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.20-13-05001.2000","article-title":"Glial cell line-derived neurotrophic factor and developing mammalian motoneurons: Regulation of programmed cell death among motoneuron subtypes","volume":"20","author":"Oppenheim","year":"2000","journal-title":"J Neurosci"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.20-02-00674.2000","article-title":"Nerve injury induces gap junctional coupling among axotomized adult motor neurons","volume":"20","author":"Chang","year":"2000","journal-title":"J Neurosci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00786","article-title":"Novel functions and signalling pathways for GDNF","volume":"116","author":"Sariola","year":"2003","journal-title":"J Cell Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.eplepsyres.2016.08.003","article-title":"Anti-mullerian hormone is higher in seizure-free women with epilepsy compared to those with ongoing seizures","volume":"127","author":"Harden","year":"2016","journal-title":"Epilepsy Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.07.321","article-title":"Association of anti-m\u00fcllerian hormone with cognitive function in Uk BioBank: a mendelian randomization study","volume":"110","author":"Nelson","year":"2018","journal-title":"Fertil Steril"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.72","article-title":"Inhibin B and anti-M\u00fcllerian hormone\/M\u00fcllerian-inhibiting substance may contribute to the male bias in autism","volume":"2","author":"Pankhurst","year":"2012","journal-title":"Transl Psychiatry"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1333-2","article-title":"Circulating anti-M\u00fcllerian hormone (AMH) associates with the maturity of boys\u2019 drawings: Does AMH slow cognitive development in males","volume":"57","author":"Morgan","year":"2017","journal-title":"Endocrine"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2008.0326","article-title":"The savant syndrome: An extraordinary condition. A synopsis: Past, present, future","volume":"364","author":"Treffert","year":"2009","journal-title":"Philos Trans R Soc B: Biol Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/6374","article-title":"Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice","volume":"2","author":"Chapman","year":"1999","journal-title":"Nat Neurosci"},{"key":"B124","doi-asserted-by":"publisher","first-page":"627.e13","DOI":"10.1016\/j.neurobiolaging.2011.04.005","article-title":"Learning capabilities and CA1-prefrontal synaptic plasticity in a mice model of accelerated senescence","volume":"33","author":"L\u00f3pez-Ramos","year":"2012","journal-title":"Neurobiol Aging"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.6.2531","article-title":"Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development","volume":"86","author":"Welt","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)60021-1","article-title":"LH\/HCG stimulation of VEGF and adrenomedullin production by follicular fluid macrophages and luteinized granulosa cells","volume":"18","author":"Guimer\u00e0","year":"2009","journal-title":"Reprod BioMed Online"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab357","article-title":"FSH-stimulated inhibin B (FSH-iB): A novel marker for the accurate prediction of pubertal outcome in delayed puberty","volume":"106","author":"Chaudhary","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2605.2000.00229.x","article-title":"Regulation of inhibin production in the human male and its clinical applications","volume":"23","author":"Anderson","year":"2000","journal-title":"Int J Androl"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des460","article-title":"Loss of LH-induced down-regulation of anti-M\u00fcllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome","volume":"28","author":"Pierre","year":"2013","journal-title":"Hum Reprod"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu142","article-title":"Biological variability in serum anti-M\u00fcllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women","volume":"29","author":"Kissell","year":"2014","journal-title":"Hum Reprod"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2016.09.023","article-title":"The role of AMH and its receptor SNP in the pathogenesis of PCOS","volume":"439","author":"Wang","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antim\u00fcllerian hormone levels (AMH): Correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): Revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.208611","article-title":"Radiolabeled antibodies against M\u00fcllerian-inhibiting substance receptor, type II: New tools for a theranostic approach in ovarian cancer","volume":"59","author":"Deshayes","year":"2018","journal-title":"J Nucl Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2011.06.006","article-title":"Is the plasma anti-M\u00fcllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome","volume":"158","author":"Ska\u0142ba","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3207-y","article-title":"The correlation between serum AMH and HOMA-IR among PCOS phenotypes","volume":"11","author":"Wiweko","year":"2018","journal-title":"BMC Res Notes"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den015","article-title":"The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome","volume":"23","author":"Chen","year":"2008","journal-title":"Hum Reprod"},{"key":"B140","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Fauser","year":"2004","journal-title":"Fertil Steril"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2016.12.004","article-title":"New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens","volume":"167","author":"Gleicher","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-015-0175-x","article-title":"Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome","volume":"8","author":"Kushnir","year":"2015","journal-title":"J Ovarian Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-017-0977-4","article-title":"Potential therapeutic applications of human anti-M\u00fcllerian hormone (AMH) analogues in reproductive medicine","volume":"34","author":"Kushnir","year":"2017","journal-title":"J Assist Reprod Genet"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2693","article-title":"Increased anti-m\u00fcllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome","volume":"91","author":"Sir-Petermann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0267","article-title":"Anti-M\u00fcllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome","volume":"92","author":"Crisosto","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem176","article-title":"A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity","volume":"22","author":"Kevenaar","year":"2007","journal-title":"Hum Reprod"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2458","article-title":"Increased frequency of the anti-m\u00fcllerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: Relationship to luteinizing hormone levels","volume":"98","author":"Georgopoulos","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0140695","article-title":"Systematic evaluation of genetic variants for polycystic ovary syndrome in a Chinese population","volume":"10","author":"Xu","year":"2015","journal-title":"PloS One"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5113","article-title":"Genome-wide association study for SNPs associated with PCOS in human patients","volume":"14","author":"Chen","year":"2017","journal-title":"Exp Ther Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2384","article-title":"Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome","volume":"44","author":"Shi","year":"2012","journal-title":"Nat Genet"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms9464","article-title":"Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome","volume":"6","author":"Day","year":"2015","journal-title":"Nat Commun"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2689","article-title":"Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genomewide association studies of chinese individuals","volume":"100","author":"Brower","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.06.015","article-title":"Highly elevated level of antim\u00fcllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction","volume":"115","author":"Kaing","year":"2021","journal-title":"Fertil Steril"},{"key":"B157","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ejogrb.2009.02.044","article-title":"Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labour","volume":"144","author":"Shynlova","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.fertnstert.2015.04.044","article-title":"Changes in antim\u00fcllerian hormone levels in early pregnancy are associated with preterm birth","volume":"104","author":"Stegmann","year":"2015","journal-title":"Fertil Steril"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-015-0082-4","article-title":"Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay","volume":"13","author":"K\u00f6ninger","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hsr2.53","article-title":"A pilot longitudinal study of anti-M\u00fcllerian hormone levels throughout gestation in low risk pregnancy","volume":"1","author":"Freeman","year":"2018","journal-title":"Health Sci Rep"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2016.1239523","article-title":"Breastfeeding and obesity in PCOS","volume":"11","author":"Harrison","year":"2016","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1080\/00016340802007676","article-title":"Breastfeeding in polycystic ovary syndrome","volume":"87","author":"Vanky","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem036","article-title":"Anti-M\u00fcllerian hormone and anti-M\u00fcllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women","volume":"22","author":"Kevenaar","year":"2007","journal-title":"Hum Reprod"},{"key":"B164","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jtbi.2013.02.007","article-title":"A lifelong model for the female reproductive cycle with an antim\u00fcllerian hormone treatment to delay menopause","volume":"326","author":"Margolskee","year":"2013","journal-title":"J Theor Biol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2093","article-title":"Relationship of serum antim\u00fcllerian hormone concentration to age at menopause","volume":"93","author":"Van Disseldorp","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1487051","DOI":"10.1155\/2016\/1487051","article-title":"Early vascular damage in young women with DM-1 and its relation to anti-M\u00fcllerian hormone: A cross-sectional study","volume":"2016","author":"De Kat","year":"2016","journal-title":"Int J Endocrinol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.07.1139","article-title":"Contribution of the rate of change of antim\u00fcllerian hormone in estimating time to menopause for late reproductive-age women","volume":"98","author":"Freeman","year":"2012","journal-title":"Fertil Steril"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.727229","article-title":"Does the anti-Mullerian hormone decline rate improve the prediction of age at menopause","volume":"12","author":"Ramezani Tehrani","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.04.006","article-title":"Correlation of ovarian reserve tests with histologically determined primordial follicle number","volume":"95","author":"Hansen","year":"2011","journal-title":"Fertil Steril"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2012\/5101.2624","article-title":"The anti Mullerian hormone-a novel marker for assessing the ovarian reserve in women with regular menstrual cycles","volume":"6","author":"Kalaiselvi","year":"2012","journal-title":"J Clin Diagn Res"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1007\/s12522-015-0227-3","article-title":"Anti-M\u00fcllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know","volume":"15","author":"Iwase","year":"2016","journal-title":"Reprod Med Biol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mce.2016.05.019","article-title":"Intra-cellular mechanism of Anti-M\u00fcllerian hormone (AMH) in regulation of follicular development","volume":"433","author":"Hayes","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20402","article-title":"Comparison of antral follicle count and serum anti M\u00fcllerian hormone level for determination of gonadotropin dosing in in-vitro fertilization: randomized trial","volume":"55","author":"Li","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4784.20.04546-3","article-title":"Anti-M\u00fcllerian hormone and embryo quality as determined by time-lapse imaging","volume":"72","author":"Korkidakis","year":"2020","journal-title":"Minerva Ginecol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dez186","article-title":"Oocyte matched follicular fluid anti-M\u00fcllerian hormone is an excellent predictor of live birth after fresh single embryo transfer","volume":"34","author":"Ciepiela","year":"2019","journal-title":"Hum Reprod"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-019-0452-4","article-title":"Prediction of the lower serum anti-M\u00fcllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys\u00ae AMH assay: A prospective observational study","volume":"17","author":"Grynnerup","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.606744","article-title":"Clinical application of AMH measurement in assisted reproduction","volume":"11","author":"Li","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-022-01016-y","article-title":"Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection","volume":"20","author":"Yang","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1177\/1179558119854755","article-title":"Anti-M\u00fcllerian hormone in fertility preservation: clinical and therapeutic applications","volume":"13","author":"Sonigo","year":"2019","journal-title":"Clin Med Insights Reprod Health"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.07.1114","article-title":"Interpreting human follicular recruitment and antim\u00fcllerian hormone concentrations throughout life","volume":"98","author":"Fleming","year":"2012","journal-title":"Fertil Steril"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1614676","article-title":"Fertility preservation in women","volume":"377","author":"Donnez","year":"2017","journal-title":"N Engl J Med"},{"key":"B183","first-page":"85","article-title":"Krioprezerwacja tkanki jajnikowej przed rozpocz\u0119ciem leczenia onkologicznego.,\u201d ONCOFERTILITY W PRAKTYCE KLINICZNEJ","author":"Wasniewski","year":"2023","journal-title":"Gdynia"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.11.043","article-title":"Prevention of chemotherapy-induced ovarian damage","volume":"105","author":"Roness","year":"2016","journal-title":"Fertil Steril"},{"key":"B186","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrd.2017.126","article-title":"Cancer immunotherapy: Macrophages steal the show","volume":"16","author":"Villanueva","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21556","article-title":"The humanized anti-human AMHRII mAb 3C23K exerts an antitumor activity against human ovarian cancer through tumorassociated macrophages","volume":"8","author":"Bougherara","year":"2017","journal-title":"Oncotarget"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301249","article-title":"Glycoengineering of therapeutic antibodies enhances monocyte\/macrophage-mediated phagocytosis and cytotoxicity","volume":"192","author":"Herter","year":"2014","journal-title":"J Immunol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/cancers13081845","article-title":"Murlentamab, a low fucosylated anti-m\u00fcllerian hormone type ii receptor (Amhrii) antibody, exhibits anti-tumor activity through tumor-associated macrophage reprogrammation and t cell activation","volume":"13","author":"Prat","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu Rev Physiol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.e23196","article-title":"Preclinical profile of GM102, a first-in-class antibody targeting AMHRII in ovarian cancers","volume":"34","author":"Barret","year":"2016","journal-title":"J Clin Oncol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2019-000472","article-title":"Circulating CD14 high CD16 low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression","volume":"8","author":"Prat","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.5542","article-title":"A first-in-human study of monoclonal antibody GM102 in patients with anti-Mullerian-hormone-receptor II (AMHRII) positive gynecological cancers","volume":"36","author":"Leary","year":"2018","journal-title":"J Clin Oncol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.2521","article-title":"First-in-human first-in-class phase I trial of murlentamab, an anti-Mullerian-hormone receptor II (AMHRII) monoclonal antibody acting through tumor-associated macrophage (TAM) engagement, as single agent and in combination with carboplatin (C) and paclitaxel (P) in AMHRII-expressing advanced\/metastatic gynecological cancer patients (pts)","volume":"37","author":"Leary","year":"2019","journal-title":"J Clin Oncol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz183.003","article-title":"Phase 2 study results of murlentamab, a monoclonal antibody targeting the Anti-Mullerian-Hormone-Receptor II (AMHRII), acting through Tumor-Associated Macrophage engagement in advanced\/metastatic colorectal cancers","volume":"30","author":"Van Cutsem","year":"2019","journal-title":"Ann Oncol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"89998","DOI":"10.18632\/oncotarget.21286","article-title":"Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer","volume":"8","author":"Kistner","year":"2017","journal-title":"Oncotarget"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6640","article-title":"New use of microsatellite instability analysis in endometrial cancer (Review)","volume":"14","author":"Kunitomi","year":"2017","journal-title":"Oncol Lett"},{"key":"B199","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pharmthera.2015.01.004","article-title":"Epithelial-mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation","volume":"150","author":"Li","year":"2015","journal-title":"Pharmacol Ther"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000288","article-title":"The expression of M\u00fcllerian inhibiting substance\/anti-M\u00fcllerian hormone type II receptor protein and mRNA in benign, borderline and Malignant ovarian neoplasia","volume":"34","author":"Song","year":"2009","journal-title":"Int J Oncol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.18.9.5380","article-title":"Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor","volume":"18","author":"Casta\u00f1o","year":"1998","journal-title":"Mol Cell Biol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.16.12.6623","article-title":"Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors","volume":"16","author":"Adams","year":"1996","journal-title":"Mol Cell Biol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2017.1338221","article-title":"Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein","volume":"16","author":"Sheldon","year":"2017","journal-title":"Cell Cycle"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05671-w","article-title":"Single cell epigenomic and transcriptomic analysis uncovers potential transcription factors regulating mitotic\/meiotic switch","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208612","article-title":"The E2F transcriptional network: Old acquaintances with new faces","volume":"24","author":"Dimova","year":"2005","journal-title":"Oncogene"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-81819-y","article-title":"Anti-M\u00fcllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells","volume":"11","author":"Chauvin","year":"2021","journal-title":"Sci Rep"},{"key":"B207","article-title":"Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS","volume":"5","author":"Masiakos","year":"1999","journal-title":"Clin Cancer Res"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2021.5223","article-title":"Anti-M\u00fcllerian hormone concentration regulates activin receptor-like kinase-2\/3 expression levels with opposing effects on ovarian cancer cell survival","volume":"59","author":"Chauvin","year":"2021","journal-title":"Int J Oncol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2017.08.011","article-title":"Role and mechanism of AMH in the regulation of Sertoli cells in mice","volume":"174","author":"ur Rehman","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.07.009","article-title":"Antim\u00fcllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study","volume":"106","author":"Kim","year":"2016","journal-title":"Fertil Steril"},{"key":"B211","article-title":"Human M\u00fcllerian inhibiting substance inhibits tumor growth in vitro and in vivo","volume":"51","author":"Chin","year":"1991","journal-title":"Cancer Res"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2003.09.010","article-title":"Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells","volume":"211","author":"Hoshiya","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod34.5.985","article-title":"Whole-mount autoradiography study of DNA synthetic activity during postnatal development and androgen-induced regeneration in the mouse prostate","volume":"34","author":"Sugimura","year":"1986","journal-title":"Biol Reprod"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.77.5.8077315","article-title":"Anti-m\u00fcllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development","volume":"77","author":"Rey","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.22.5.0445","article-title":"M\u00fcllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications","volume":"22","author":"Teixeira","year":"2001","journal-title":"Endocr Rev"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M103092200","article-title":"Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo","volume":"276","author":"Segev","year":"2001","journal-title":"J Biol Chem"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2010.05.004","article-title":"Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy","volume":"1799","author":"Gupta","year":"2010","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)01109-0","article-title":"The promoter of human p22\/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NF\u03baB","volume":"436","author":"Sch\u00e4fer","year":"1998","journal-title":"FEBS Lett"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm (Beijing)"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M108674200","article-title":"NF-\u03baB activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells","volume":"276","author":"Bian","year":"2001","journal-title":"J Biol Chem"},{"key":"B221","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1600-065X.2012.01099.x","article-title":"NF-\u03baB and the link between inflammation and cancer","volume":"246","author":"Didonato","year":"2012","journal-title":"Immunol Rev"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9080889","article-title":"NF-\u03baB and human cancer: what have we learned over the past 35 years","volume":"9","author":"Gilmore","year":"2021","journal-title":"Biomedicines"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2016.01.001","article-title":"Role of the RANK\/RANKL pathway in breast cancer","volume":"86","author":"Kiesel","year":"2016","journal-title":"Maturitas"},{"key":"B224","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","article-title":"The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01298-06","article-title":"RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini","volume":"27","author":"Gonzalez-Suarez","year":"2007","journal-title":"Mol Cell Biol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3049-9","article-title":"RANKL expression in normal and Malignant breast tissue responds to progesterone and is up-regulated during the luteal phase","volume":"146","author":"Hu","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v4.i4.178","article-title":"Role of RANKL\/RANK in primary and secondary breast cancer","volume":"4","author":"Yoneda","year":"2013","journal-title":"World J Orthop"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2015.07.012","article-title":"Epithelial-mesenchymal plasticity: A central regulator of cancer progression","volume":"25","author":"Ye","year":"2015","journal-title":"Trends Cell Biol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00599-2","article-title":"IKK\u03b1 Provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development","volume":"107","author":"Cao","year":"2001","journal-title":"Cell"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.26.3.1002-1013.2006","article-title":"Receptor activator of NF-\u03baB ligand regulates the proliferation of mammary epithelial cells via id2","volume":"26","author":"Kim","year":"2006","journal-title":"Mol Cell Biol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S1470-2045(19)30687-4","article-title":"Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial","volume":"21","author":"Coleman","year":"2020","journal-title":"Lancet Oncol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-23-0060","article-title":"The roles of anti-M\u00fcllerian hormone in breast cancer","volume":"30","author":"Chen","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-4-152","article-title":"Serum M\u00fcllerian inhibiting substance levels are lower in premenopausal women with breast precancer and cancer","volume":"4","author":"McCoy","year":"2011","journal-title":"BMC Res Notes"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2361-5","article-title":"Impact of breast cancer on anti-mullerian hormone levels in young women","volume":"137","author":"Su","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.18502\/ijrm.v19i2.8476","article-title":"Abnormal anti-m\u00fcllerian hormone level may be a trigger for breast cancer in young women: A case-control study","volume":"19","author":"Jalaeefar","year":"2021","journal-title":"Int J Reprod BioMed"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-14-0377","article-title":"Anti-m\u00fcllerian hormone concentrations in premenopausal women and breast cancer risk","volume":"8","author":"Nichols","year":"2015","journal-title":"Cancer Prev Res"},{"key":"B237","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/life13040930","article-title":"Impact of breast cancer and germline BRCA pathogenic variants on fertility preservation in young women","volume":"13","author":"Prokurotaite","year":"2023","journal-title":"Life"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-019-01658-9","article-title":"Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer","volume":"37","author":"Porcu","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06508-w","article-title":"Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer","volume":"192","author":"Anderson","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.11005\/JBM.2021.28.3.223","article-title":"Anti-M\u00fcllerian hormone negatively regulates osteoclast differentiation by suppressing the receptor activator of nuclear factor-\u03baB ligand pathway","volume":"28","author":"Kim","year":"2021","journal-title":"J Bone Metab"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4525","article-title":"Anti-Mullerian hormone as predictor of future and ongoing bone loss during the menopause transition","volume":"37","author":"Karlamangla","year":"2022","journal-title":"J Bone Mineral Res"},{"key":"B242","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/1354750X.2020.1833083","article-title":"Serum anti-M\u00fcllerian hormone levels are associated with low bone mineral density in premenopausal women","volume":"25","author":"Yan","year":"2020","journal-title":"Biomarkers"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4567","article-title":"Serum AMH levels: an early reproductive marker for bone loss","volume":"37","author":"Visser","year":"2020","journal-title":"J Bone Mineral Res"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.666687","article-title":"Relationship between vitamin D and hormones important for human fertility in reproductive-aged women","volume":"12","author":"Chu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12061567","article-title":"The association between vitamin d and anti-M\u00fcllerian hormone: A systematic review and meta-analysis","volume":"12","author":"Moridi","year":"2020","journal-title":"Nutrients"},{"key":"B246","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-021-00786-7","article-title":"Does vitamin D supplementation improve ovarian reserve in women with diminished ovarian reserve and vitamin D deficiency: a before-and-after intervention study","volume":"21","author":"Aramesh","year":"2021","journal-title":"BMC Endocr Disord"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1468364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:42:48Z","timestamp":1726447368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1468364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":246,"alternative-id":["10.3389\/fendo.2024.1468364"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1468364","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"article-number":"1468364"}}